Choice of Law Clause Example from Business Contracts
This example Choice of Law clause appears in 17 contracts from 11 companies
Amended and Restated Pharmaceuticals, Inc. Inducement Plan (Filed With SEC on March 1, 2019)
Portola Pharmaceuticals, Inc. 2013 Equity Incentive Plan and Amendment dated February 27, 2019 (Filed With SEC on May 8, 2019)
Portola Pharmaceuticals, Inc. Amended and Restated Inducement Plan and Amendment dated February 27, 2019 (Filed With SEC on May 8, 2019)
Yelp Inc. 2012 Equity Incentive Plan, as Amended (Filed With SEC on February 13, 2019)
Amended and Restated 2005 Stock Option/Stock Issuance Plan and Form of Stock Option Grant Notice, Option Agreement and Form of Notice of Exercise (Filed With SEC on July 17, 2019)
2015 Stock Option/Stock Issuance Plan and Form of Stock Option Grant Notice, Option Agreement, Form of Notice of Exercise, Form of Restricted Stock Unit Award Grant Notice and... (Filed With SEC on July 17, 2019)
Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on February 27, 2019)
Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on November 8, 2018)
TOCAGEN INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: APPROVED BY THE STOCKHOLDERS: IPODATE: (Filed With SEC on March 9, 2017)
Avidity Biosciences, Inc. 2013 Amended and Restated Equity Incentive Plan, including form of stock option grant notice and stock option agreement thereunder (Filed With SEC on May 22, 2020)
Metacrine, Inc. Amended and Restated 2015 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder, as amended (Filed With SEC on August 24, 2020)
Revance Therapeutics, Inc. Amended and Restated 2014 Inducement Plan (Filed With SEC on November 9, 2020)
Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on March 19, 2021)
Reneo Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, and UK Sub-Plan (Filed With SEC on April 5, 2021)
aTyr Pharma, Inc. 2022 Inducement Plan (Filed With SEC on May 10, 2022)
2013 Equity Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on June 25, 2018)
Xencor, Inc. 2013 Equity Incentive Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder (Filed With SEC on February 28, 2018)
